GLI1 and neoplasm: In conclusion, our work establishes STK38 as a central coordinator of cellular plasticity and intratumoral heterogeneity in pRCC, and identifies GLI1 inhibition as a promising means of disrupting oncogenic self-renewal programs in aggressive tumor subsets.